Balancing tests in the field provide important information about the physical fitness and injury risk of athletes. These tests provide useful data on an athlete's ability to maintain balance in dynamic and unforeseen circumstances, allowing for a more detailed assessment of their athletic performance. We have designed a novel balance test and tested main quality criteria and competitiveness for it. A total of 117 children (girls = 52.1%) aged 10.4 years participated in the tests. The raw ABC scores show good to excellent test-retest reliability for all participants. Girls show a higher reliability (excellent) than boys (moderate to good). The comparison of raw data of the performance in the ABC and existing balance field tests shows strong correlation of the results. The test duration of the ABC is significantly (p<.001) shorter than that of existing balance field tests. The statistical and graphical analysis of the calculation of the normal distribution shows that the results of the ABC are closer to the normal distribution than those of the existing balance field tests. The combination of high reliability and competitiveness makes the Austrian Balance Check an extremely attractive option for various areas of application. Overall, the novel designed test is a promising instrument that has the potential to significantly improve the standards of balance testing procedures in the field. The authors recommend a large-scale study to review the test quality criteria of the ABC, including gold standard comparison and development of age- and gender-specific reference values, in order to increase interest in implementing the Austrian Balance Check in international test batteries.

The authors have declared no competing interest.

This research was funded by the Austrian Federal Ministry for Arts, Culture, Civil Service, and Sport, grant number GZ2021-0.361.671

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This was approved by the Research Ethics Committee of the University of Graz, Styria, Austria (GZ. 39/23/63 ex 2018/1/9).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

All data produced in the present work are contained in the manuscript